Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 126Breast Neoplasms 78Neoplasms 48Prostatic Neoplasms 19Fatigue 16Obesity 14Colorectal Neoplasms 13Lung Neoplasms 11Polycystic Ovary Syndrome 10Colonic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Weight Loss 6Ovarian Neoplasms 6Rectal Neoplasms 5Multiple Myeloma 5Lymphedema 5Leukemia 5Inflammation 5Pancreatic Neoplasms 4Overweight 4Multiple Endocrine Neoplasia Type 1 4Lymphoma 4Leukemia, Myeloid, Acute 4Insulin Resistance 4Depression 4Cognitive Dysfunction 4Brain Neoplasms 4Stomach Neoplasms 3Peripheral Nervous System Diseases 3

Interventions

Sorafenib 121Nivolumab 36pembrolizumab 32Bevacizumab 28lenvatinib 27Doxorubicin 23Radiosurgery 21Radiofrequency Ablation 20Oxaliplatin 20Hepatectomy 18Fluorouracil 15Capecitabine 15Magnetic Resonance Spectroscopy 14atezolizumab 13Leucovorin 13Cisplatin 13Gemcitabine 11Erlotinib Hydrochloride 11tislelizumab 9Sirolimus 9Radiotherapy 9Irinotecan 9Ipilimumab 9cabozantinib 8Liver Transplantation 8regorafenib 7Ramucirumab 7Folfox protocol 7Embolization, Therapeutic 7sintilimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Hepatocellular × Exercise × Clear all
NCT00355238 2023-12-01

A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer

Bristol-Myers Squibb

Phase 2 Completed
137 enrolled 20 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡